Substance P

Substance P has been studied in 2 papers since 2023: none in people yet, 1 in animals, 1 in cells. The research so far is in animals and cells. The newest paper, Nov 22, 2023: “Preconditioning with Substance P Restores Therapeutic Efficacy of Aged ADSC by Elevating TNFR2 and Paracrine Potential”.

Intervention

2 papers study it24 more mention it2 findingsUpdated

PubChemChEBIMeSH

  • 1 lab in 1 country
  • Funders: Government of the Republic of Korea and 1 more
  • Animals1
  • Cells1

What did studies of Substance P find?

2

Studies of Substance P measured 2 outcomes; the most studied are TNFRSF1B (1 study) and cell viability (1).

TNFRSF1B

upin cells1

1 study
  1. Substance P increases TNFRSF1B in cells.

    “restored TNFR2 expression and paracrine potential, similar to ADSC-Y under inflammatory conditions”

    Cellsunder inflammatory conditions (TNF-α exposure)24 h

    Preconditioning with Substance P Restores Therapeutic Efficacy of Aged ADSC by Elevating TNFR2 and Paracrine Potential

    Biology

More on TNFRSF1B

Cell viability

upin cells1

1 study
  1. Substance P increases cell viability in cells.

    “preconditioning with SP significantly enhanced the viability of ADSCs-E”

    Cellsunder inflammatory conditions (TNF-α exposure)24 h

    Preconditioning with Substance P Restores Therapeutic Efficacy of Aged ADSC by Elevating TNFR2 and Paracrine Potential

    Biology

More on Cell viability

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 1Feb 2026: 0Mar 2026: 1Apr 2026: 1May 2026: 0Jun 2026: 1Jul 2026: 1Aug 2026: 0Sep 2026: 1Oct 2026: 17 papers in 12 months